Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection

Journal of Gastroenterology

Volumn 44, Issue SUPPL. 19, 2009, Pages 82-88

  Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Intracellular signal transduction; Lipid metabolism; Oxidative stress; Peroxisome proliferator activated receptor; Transgenic mouse

Indexed keywords

ACYL COENZYME A OXIDASE; CELLULAR RETINOL BINDING PROTEIN; CORE PROTEIN; FATTY ACID; K RAS PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEASOME; PROTEIN P53; RETINOID X RECEPTOR ALPHA;

ARTICLE; AUTOIMMUNE HEPATITIS; CANCER CELL; CANCER GROWTH; CANCER RISK; CELL PROLIFERATION; CLINICAL FEATURE; COLON CARCINOGENESIS; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; FATTY LIVER; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE TARGETING; GENETIC DISORDER; GENETIC RISK; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSULIN RESISTANCE; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; LIVER MITOCHONDRION; METABOLIC DISORDER; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TRANSGENE; UPREGULATION; VIRUS GENE; VIRUS GENOME; VIRUS VIRULENCE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; FATTY LIVER; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; PPAR ALPHA;

EID: 58849166220     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2276-4     Document Type: Article

References (34)

1. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547-6549.
2. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients. J Hepatol 1998;28:930-938.
3. Okuse C, Yotsuyanagi H, Koike K. Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations. J Gastroenterol 2007;42:857-865.
4. Koike K, Moriya K. Metabolic aspects of hepatitis C: Steatohepatitis distinct from NASH. J Gastroenterol 2005;40:329-336.
5. Negro F. Insulin resistance and HCV: Will new knowledge modify clinical management? J Hepatol 2006;45:514-519.
6. Powell EE, Jonsson JR, Clouston AD. Steatosis: Co-factor in other liver diseases. Hepatology 2005;42:5-13.
7. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-675.
8. Yotsuyanagi H, Shintani Y, Moriya K, Fujie H, Tsutsumi T, Kato T, et al. Virological analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis 2000;181:1920-1928.
9. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997;78:1527-1531.
10. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Matsuura Y, et al. Hepatitis C virus core protein induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-1068.
11. Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, et al. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76:3031-3038.
12. Koike K, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, et al. Sialadenitis resembling Sjögren's syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997;94:233-236.
13. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis. Hepatology 1992;15:572-577.
14. Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002;122:352-365.
15. Naas T, Ghorbani M, Alvarez-Maya I, Lapner M, Kothary R, De Repentigny Y, et al. Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2. J Gen Virol 2005;86:2185-2196.
16. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 2006;80:7199-7207.
17. Moriya K, Fujie H, Yotsuyanagi H, Shintani Y, Tsutsumi T, Matsuura Y, et al. Subcellular localization of hepatitis C virus structural proteins expressed in transgenic liver. Jpn J Med Sci Biol 1997;50:169-177.
18. Sasaki Y. Does oxidative stress participate in the development of hepatocellular carcinoma? J Gastroenterol 2006;41:1135-1148.
19. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocellular carcinogenesis. Cancer Res 2001;61:4365-4370.
20. Moriya K, Todoroki T, Tsutsumi T, Fujie H, Shintani Y, Miyoshi H, et al. Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: Analysis in transgenic mice and humans. Biophys Biochem Res Commun 2001;281:1207-1212.
21. Okuda M, Li K, Beard MR, Showalter LA, Schole F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366-375.
22. Tsutsumi T, Suzuki T, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, et al. Intrahepatic cytokine expression and AP-1 activation in mice transgenic for hepatitis C virus core protein. Virology 2002;304:415-424.
23. Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 2003;38:820-828.
24. Miyamoto H, Moriishi K, Moriya K, Murata S, Tanaka K, Suzuki T, et al. Hepatitis C virus core protein induces insulin resistance through a PA28γ-dependent pathway. J Virol 2007;81:1727-1735.
25. Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Kimura S, Moriya K, et al. Hepatitis C virus and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004;126:840-848.
26. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Koike K, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: A model of viral-related steatosis. FASEB J 2002;16:185-194.
27. Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, et al. Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci USA 2007;104:1661-1666.
28. Tsutsumi T, Suzuki T, Shimoike T, Moriya K, Yotsuyanagi H, Matsuura Y, et al. Interaction of hepatitis C virus core protein with retinoid X receptor-α modulates its transcriptional activity. Hepatology 2002;35:937-946.
29. Peters JM, Cheung C, Gonzalez FJ. Peroxisome proliferatoractivated receptor-alpha and liver cancer: Where do we stand? J Mol Med 2005;83:774-785.
30. Tanaka N, Moriya K, Kiyosawa K, Koike K, Aoyama T. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: Implications for HCV-associated hepatocarcinogenesis. Int J Cancer 2008;122:124-131.
31. Akiyama TE, Sakai S, Lambert G, Nicol CJ, Matsusue K, Pimprale S, et al. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 2002;22:2607-2619.
32. Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T. PPAR-α is essential for severe hepatic steatosis and hepatocellular carcinoma induced by HCV core protein. J Clin Invest 2008;118:683-694.
33. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
34. Koike K. Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: Lessons from animal model studies. Clin Gastroenterol Hepatol 2005;3:S132-S135.